Menu Search
Equities

Omeros Corp

OMER:NMQ

Omeros Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)4.26
  • Today's Change-0.03 / -0.70%
  • Shares traded303.01k
  • 1 Year change+240.80%
  • Beta1.4887
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Omeros Corp fell by 3.90m. However, the company earned 74.73m from its operations for a Cash Flow Margin of --. In addition the company generated 27.45m cash from investing, though they paid out 106.08m more in financing than they received.
Cash flow per share-3.29
Price/Cash flow per share--
Book value per share-2.15
Tangible book value per share-2.15
More ▼

Balance sheet in USDView more

Omeros Corp has a Debt to Total Capital ratio of 141.73%, a lower figure than the previous year's 1,669.70%.
Current ratio3.41
Quick ratio--
Total debt/total equity--
Total debt/total capital1.42
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.